Clinical Gut Health Intelligence
Providing the latest research on the original De Simone Formulation (CDS22) and high-potency microbiome support in the UK. All content is clinically reviewed to ensure accuracy for patients and healthcare professionals.
The UK’s Specialist Hub for Probiotic Evidence & Gut Health Research
Welcome to the Probiotics UK & Gut Health Knowledge Hub, the central resource for evidence-based research on the original De Simone Formulation (CDS22). This hub provides UK readers, patients, and healthcare professionals with clinical guides, high-potency strain comparisons, and the latest gastroenterology updates dispatched from our Lancashire facility.
Every article published here is curated to support the NHS IBD care pathways and private clinical protocols. We focus exclusively on the Original 8-Strain De Simone Formulation (CDS22), ensuring our readers have access to the exact science backed by over 200 peer-reviewed studies. From our cold-chain facility in Chorley, we monitor the latest developments in gut health to keep the UK medical community informed.
A clear, factual comparison of CDS22-formula and VSL#3 in the UK, explaining the history of the original De Simone Formulation, key differences, and what they mean for customers today.
Read more
Wondering what happened to Vivomixx Probiotic in the UK? The original formulation, once known as VSL#3, has been discontinued and replaced with CDS22-Formula—which contains the exact same clinically validated probiotic blend. Meanwhile, Vivomixx Neo is an entirely new formulation with untested bacterial strains and no proven clinical trials. If you’re looking for a trusted, scientifically backed probiotic, CDS22-Formula remains the best alternative, delivering 450 billion CFU per sachet with over 80+ clinical studies supporting its effectiveness. Stick with the original—shop CDS22-Formula today!
Read more